Cardiac123I-MIBG scintigraphic findings and REM sleep behavior disorder
- 7 March 2013
- book chapter
- Published by Cambridge University Press (CUP)
- p. 333-339
Abstract
A recent double-blind, placebo-controlled study investigated the effect of modafinil on cortical excitability in narcolepsy by means of transcranial magnetic stimulation (TMS) and explored the relation between these TMS measures and conventional measures of sleepiness. Electroencephalographic (EEG) low-resolution brain electromagnetic tomography (LORETA) was developed in order to identify brain regions that are involved in neuropsychiatric disorders and are the targets of therapeutic drug action. Modafinil did not influence thymopsychic variables in narcolepsy, but it significantly improved cognitive performance, which may be related to medial prefrontal activity processes identified by LORETA. To bridge the currently wide gap between the neurotransmitter and the behavioral level and to improve temporal resolution up to the millisecond level, it may be useful to study the individual components of event-related brain potentials (ERPs). The ERP study revealed significantly shortened N2 and P300 latencies under modafinil compared with placebo, which reflects an improvement of information processing speed.Keywords
This publication has 40 references indexed in Scilit:
- Cardiac autonomic dysfunction in idiopathic REM sleep behavior disorderMovement Disorders, 2010
- Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorderNeurology, 2009
- Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's diseaseAnnals of Neurology, 2009
- 123I‐metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disordersMovement Disorders, 2009
- Manifestations of Parkinson disease differ in association with REM sleep behavior disorderMovement Disorders, 2008
- Impaired cardiovascular autonomic function in Parkinson's disease with visual hallucinationsMovement Disorders, 2007
- Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's diseaseMovement Disorders, 2007
- Degeneration of Cardiac Sympathetic Nerve Begins in the Early Disease Process of Parkinson’s DiseaseBrain Pathology, 2007
- Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorderNeurology, 1996
- A scintigraphical qualitative analysis of peripheral vascular sympathetic function with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failureJournal of the Autonomic Nervous System, 1995